ASMB.NASDAQAssembly Biosciences, INC
Form 4: Assembly Biosciences Director Receives Stock Options
Sentiment:
SEC Form 4 Filing
Susan Mahony, a director at Assembly Biosciences, was granted stock options to purchase 2,750 shares of common stock.
Summary
- On May 29, 2024, Susan Mahony, a director of Assembly Biosciences, Inc., received stock options for 2,750 shares of common stock.
- The exercise price of these options is $15.06 per share.
- The options vest on the earlier of May 29, 2025, or the date of the Issuer's 2025 annual meeting of stockholders, assuming continuous service.
- The options expire on May 29, 2034.
Sentiment
Score: 5
Explanation: The document is a standard SEC Form 4 filing, indicating a routine grant of stock options to a company director. It doesn't inherently convey positive or negative sentiment.
Stakeholder Impact
- The grant of stock options may incentivize the director to work towards increasing shareholder value.
Key Dates
| Date | Description |
|---|---|
| 05/29/2024 | Date of transaction: Grant of stock options. |
| 05/29/2025 | Earliest vesting date for the stock options. |
| 05/29/2034 | Expiration date of the stock options. |
| 05/30/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.